Jw Life Science Corp (234080) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.053x

Based on the latest financial reports, Jw Life Science Corp (234080) has a cash flow conversion efficiency ratio of 0.053x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩11.29 Billion ≈ $7.65 Million USD) by net assets (₩214.86 Billion ≈ $145.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jw Life Science Corp - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Jw Life Science Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jw Life Science Corp total liabilities for a breakdown of total debt and financial obligations.

Jw Life Science Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jw Life Science Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Benchmark Holdings Plc LSE:BMK	0.036x
Berkeley Energia Ltd AU:BKY	0.000x
Interactive Digital Technologies TWO:6486	-0.067x
Asia Electronic Material Co Ltd TWO:4939	-0.018x
GREENLAND RESOURCES INC. F:M0LY	N/A
Pantech Group Holdings Bhd KLSE:5125	0.057x
RCM Technologies Inc NASDAQ:RCMT	-0.030x
Lindsell Train Investment Trust Plc LSE:LTI	0.018x

Annual Cash Flow Conversion Efficiency for Jw Life Science Corp (2015–2024)

The table below shows the annual cash flow conversion efficiency of Jw Life Science Corp from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Jw Life Science Corp worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩200.44 Billion ≈ $135.84 Million	₩50.69 Billion ≈ $34.35 Million	0.253x	+7.28%
2023-12-31	₩159.39 Billion ≈ $108.02 Million	₩37.57 Billion ≈ $25.46 Million	0.236x	+134.14%
2022-12-31	₩140.33 Billion ≈ $95.10 Million	₩14.13 Billion ≈ $9.57 Million	0.101x	-56.11%
2021-12-31	₩131.49 Billion ≈ $89.11 Million	₩30.17 Billion ≈ $20.44 Million	0.229x	-35.20%
2020-12-31	₩132.06 Billion ≈ $89.50 Million	₩46.75 Billion ≈ $31.68 Million	0.354x	+78.82%
2019-12-31	₩122.62 Billion ≈ $83.09 Million	₩24.28 Billion ≈ $16.45 Million	0.198x	-40.13%
2018-12-31	₩109.26 Billion ≈ $74.04 Million	₩36.13 Billion ≈ $24.48 Million	0.331x	+53.12%
2017-12-31	₩102.10 Billion ≈ $69.19 Million	₩22.05 Billion ≈ $14.94 Million	0.216x	+21.27%
2016-12-31	₩90.30 Billion ≈ $61.20 Million	₩16.08 Billion ≈ $10.90 Million	0.178x	-43.04%
2015-12-31	₩82.83 Billion ≈ $56.13 Million	₩25.90 Billion ≈ $17.55 Million	0.313x	--

About Jw Life Science Corp

KO:234080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$135.68 Million

₩200.22 Billion KRW

Market Cap Rank

#18022 Global

#884 in Korea

Share Price

₩12930.00

Change (1 day)

-1.30%

52-Week Range

₩11400.00 - ₩15500.00

All Time High

₩26817.34